79 results match your criteria: "Caremeau Hospital[Affiliation]"

Background: Independent use of artificial intelligence with computer-aided detection (CADe) and Endocuff Vision (ECV) has demonstrated enhanced adenoma detection rates (ADRs).

Objective: Our pilot study aimed to define the necessary participant number for future randomized controlled trials (RCTs) by comparing the ADR of combined CADe + ECV against CADe alone and standard colonoscopy.

Design: This single-center pilot study retrospectively analyzed a prospectively maintained database, where patients underwent screening colonoscopies sequentially by standard method, CADe alone, and then CADe + ECV.

View Article and Find Full Text PDF

Predictors of pain during phacoemulsification under local sedation: A multicentric study.

J Fr Ophtalmol

October 2024

Department of Ophthalmology, Gui-de-Chauliac Hospital, 80, avenue Augustin-Fliche, 34000 Montpellier, France; Institute for Neurosciences of Montpellier INM, University Montpellier, Inserm, 34091 Montpellier, France; The Save Sight Institute, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. Electronic address:

Purpose: To assess the risk factors for pain during cataract surgery under local anesthesia.

Methods: This multicentric observational study assessed risk factors for pain during cataract surgery from June to November 2020 in a private clinic and two university hospitals (France). Adults who underwent cataract surgery under local anesthesia with conscious sedation were consecutively included.

View Article and Find Full Text PDF
Article Synopsis
  • The approval of biosimilars for treating inflammatory bowel diseases (IBDs) helps address rising healthcare costs and improve treatment availability, particularly for Crohn's disease (CD).
  • Since 2013, many biosimilars have been approved in Europe, with substantial clinical studies demonstrating their effectiveness in CD treatment across a diverse patient population.
  • Experts recommend integrating biosimilars into standard clinical practice due to their proven efficacy and safety, as evidenced by significant increases in usage rates for infliximab and adalimumab in European countries.
View Article and Find Full Text PDF

Background: Methotrexate, an immunosuppressant used for the treatment of inflammatory bowel disease (IBD) for over 30 years, remains underused compared to thiopurines.

Aims: To review the efficacy, safety, optimal dosing and delivery regimens of methotrexate in adults with IBD.

Methods: We conducted a systematic review of studies involving patients with IBD treated with methotrexate from inception to August 2023.

View Article and Find Full Text PDF

From physiological awakening to pathological sleep inertia: Neurophysiological and behavioural characteristics of the sleep-to-wake transition.

Neurophysiol Clin

April 2024

Lyon Neuroscience Research Centre, INSERM U1028, CNRS UMR 5292, Lyon, France; Centre for Sleep Medicine and Respiratory Diseases, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon 1 University, Lyon, France. Electronic address:

Sleep inertia refers to the transient physiological state of hypoarousal upon awakening, associated with various degrees of impaired neurobehavioral performance, confusion, a desire to return to sleep and often a negative emotional state. Scalp and intracranial electro-encephalography as well as functional imaging studies have provided evidence that the sleep inertia phenomenon is underpinned by an heterogenous cerebral state mixing local sleep and local wake patterns of activity, at the neuronal and network levels. Sleep inertia is modulated by homeostasis and circadian processes, sleep stage upon awakening, and individual factors; this translates into a huge variability in its intensity even under physiological conditions.

View Article and Find Full Text PDF

Long sleep time and excessive need for sleep: State of the art and perspectives.

Neurophysiol Clin

April 2024

APHM, Timone hospital, Sleep Unit, Epileptology and Cerebral Rhythmology, Marseille, France; Aix Marseille Univ, INSERM, INS, Inst Neurosci Syst, Marseille, France. Electronic address:

The mechanisms underlying the individual need for sleep are unclear. Sleep duration is indeed influenced by multiple factors, such as genetic background, circadian and homeostatic processes, environmental factors, and sometimes transient disturbances such as infections. In some cases, the need for sleep dramatically and chronically increases, inducing a daily-life disability.

View Article and Find Full Text PDF

HLA in isolated REM sleep behavior disorder and Lewy body dementia.

Ann Clin Transl Neurol

September 2023

Department of Human Genetics, McGill University, Montréal, Québec, Canada.

Article Synopsis
  • A study investigated the relationship between the human leukocyte antigen (HLA) locus and synucleinopathies, specifically Lewy body dementia (LBD) and isolated REM sleep behavior disorder (iRBD), which are linked to neuroinflammation.
  • It was found that the HLA-DRB1*11:01 allele was significantly associated with iRBD, while several other alleles showed varying associations.
  • The results imply that the HLA locus may have distinct roles depending on the type of synucleinopathy being examined.
View Article and Find Full Text PDF

Unplanned surgery after colorectal resection: laparoscopy at the index surgery is a protective factor against mortality.

Surg Endosc

September 2023

Fédération de Chirurgie Viscérale et Digestive (FCVD), 12 Rue Bayard, 31000, Toulouse, France.

Background: The aim of this study was to assess risk factors of mortality after unplanned surgery following colorectal resection.

Methods: All the consecutive patients who underwent colorectal resection between 2011 and 2020 in a French national cohort were retrospectively included. Perioperative data of the index colorectal resection (indication, surgical approach, pathological analysis, postoperative morbidity), and characteristics of unplanned surgery (indication, time to complication, time to surgical redo) were assessed in order to identify predictive factors of mortality.

View Article and Find Full Text PDF
Article Synopsis
  • Sleep disturbances following ischaemic stroke can include issues like obstructive sleep apnea, insomnia, and restless legs syndrome, which may impact recovery.
  • In a study involving 90 stroke patients, severe obstructive sleep apnea was assessed and participants were divided into two groups: one receiving continuous positive airway pressure (CPAP) treatment and the other receiving a placebo.
  • Functional independence and other outcomes were measured at three months post-stroke, revealing no significant difference between CPAP and placebo in improving these scores, while factors like insomnia and decreased total sleep time correlated with poorer recovery.
View Article and Find Full Text PDF

Background: Hyperoxia is common during liver transplantation (LT), without being supported by any guidelines. Recent studies have shown the potential deleterious effect of hyperoxia in similar models of ischemia-reperfusion. Hyperoxia after graft reperfusion during orthotopic LT could increase lactate levels and worsen patient outcomes.

View Article and Find Full Text PDF

Upfront Laparoscopic Management of Common Bile Duct Stones: What Are the Risk Factors of Failure?

J Gastrointest Surg

September 2023

Digestive and Minimally Invasive Surgery Unit, Department of Digestive Surgery and Transplantation, Saint Eloi Hospital, University of Montpellier - Nîmes, 80 Avenue Augustin Fliche, 34295, Montpellier, France.

Background: Treatment of common bile duct stones (CBDS) includes laparoscopic cholecystectomy (LC) with either laparoscopic common bile duct exploration (LCBDE) or perioperative endoscopic retrograde cholangiopancreatography (ERCP). The main objective of this study was to identify predictive factors for the failure of upfront and exclusive surgical treatment by LCBDE.

Methods: This is a single-center, retrospective study on patients with CBDS and operated for LC between 2007 and 2019.

View Article and Find Full Text PDF

NPC1 variants are not associated with Parkinson's disease, REM-sleep behavior disorder or dementia with Lewy bodies in European cohorts.

Neurobiol Aging

July 2023

The Neuro (Montréal Neurological Institute-Hospital), McGill University, Montréal, Quebec, Canada; Department of Human Genetics, McGill University, Montréal, Quebec, Canada; Department of Neurology and Neurosurgery, McGill University, Montréal, Quebec, Canada. Electronic address:

Article Synopsis
  • NPC1 is a gene that encodes a protein crucial for cholesterol transport in lysosomes, and mutations in this gene can cause Niemann-Pick disease type C, a lysosomal storage disorder.
  • This study investigated the potential link between NPC1 variants and several alpha synucleinopathies, including Parkinson's disease, dementia with Lewy bodies, and rapid eye movement-sleep behavior disorder, using data from multiple cohorts of individuals of European descent.
  • The results showed that neither common nor rare NPC1 variants were associated with these neurodegenerative disorders, indicating that NPC1 mutations likely do not significantly impact the development of alpha synucleinopathies.
View Article and Find Full Text PDF

Anti-SAE autoantibody in dermatomyositis: original comparative study and review of the literature.

Rheumatology (Oxford)

December 2023

Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière University Hospital, Sorbonne Université, AP-HP, Paris, France.

Objective: Among specific autoantibodies in DM, the anti-small ubiquitin-like modifier activating enzyme (SAE) antibody is rare. We aim to describe the clinical characteristics, cancer prevalence, and muscle pathology of anti-SAE-positive DM.

Methods: Patients with a diagnosis of DM and sera positive for the anti-SAE antibody were recruited from 19 centres in this retrospective observational study.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the role of the human leukocyte antigen (HLA) locus in isolated REM sleep behavior disorder (iRBD), Lewy body dementia (LBD), and Parkinson's disease (PD), highlighting the genetic and neuroinflammatory links between these synucleinopathies.
  • - Researchers performed genetic analyses using data from over 1,000 iRBD patients and 2,600 LBD patients to identify associations between specific HLA alleles and disease susceptibility, finding strong links for certain alleles in iRBD but not in LBD.
  • - The results indicate a unique association of the HLA allele *11:01 with iRBD, suggesting that the genetic factors may differ between these
View Article and Find Full Text PDF

C5b-9 Glomerular Deposits Are Associated With Poor Renal Survival in Membranous Nephropathy.

Kidney Int Rep

January 2023

Department of Nephrology, Dialysis and Transplantation, Lapeyronie Hospital, Montpellier University Hospital, University of Montpellier, Montpellier, France.

Introduction: Membranous nephropathy (MN) is the first cause of nephrotic syndrome in patients without diabetes. Its prognosis is variable, and treatment remains controversial because of potential toxicity. Currently, there is no reliable prognostic marker common to all etiologies of MN and routinely available to predict the disease course and guide therapeutic management.

View Article and Find Full Text PDF
Article Synopsis
  • * A genome-wide association study identified five genetic risk loci for RBD near specific genes (SNCA, GBA, TMEM175, INPP5F, and SCARB2), suggesting a genetic basis for the disorder.
  • * Further analysis indicates that certain genes, like SNCA-AS1, show different expression levels in various brain regions affected by RBD, paving the way for recognizing RBD as a distinct subtype of alpha-synucleinopathy for potential early interventions.
View Article and Find Full Text PDF

Steroid hormone catabolites activate the pyrin inflammasome through a non-canonical mechanism.

Cell Rep

October 2022

CIRI, Centre International de Recherche en Infectiologie, Inserm U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, University Lyon, 69007 Lyon, France. Electronic address:

The pyrin inflammasome acts as a guard of RhoA GTPases and is central to immune defenses against RhoA-manipulating pathogens. Pyrin activation proceeds in two steps. Yet, the second step is still poorly understood.

View Article and Find Full Text PDF

Change in Sleep Quality of Residents the Night Before High-Fidelity Simulation: Results From a Prospective 1-Year National Survey.

Turk J Anaesthesiol Reanim

August 2022

Department of Anaesthesiology and Reanimation, Hospices Civils de Lyon, Lyon, France; Lyonnais Center for Education by Simulation in Health, Claude Bernard Lyon 1 University, SAMSEI, Lyon, France; Research on Healthcare Performance (RESHAPE), Claude Bernard Lyon 1 University, Lyon, France.

Objective: The stress level of participants in high-fidelity simulation stems from various factors but may result in anticipatory anxiety causing sleep disturbances during the night prior to simulation. The objective of this survey was to determine the change in sleep quality of residents during the night prior to the simulation.

Methods: The survey was proposed for 1 year to all residents at the beginning of the simulation, in 10 simulation centres.

View Article and Find Full Text PDF

Nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin (acetylsalicylic acid), diclofenac and ibuprofen (IBU), and analgesic drugs, such as acetaminophen (APAP, or paracetamol), are widely used to treat inflammation and pain. APAP and IBU are over-the-counter drugs and are among the most commonly taken drugs in the first trimester of pregnancy, even in combination. Furthermore, these drugs and their metabolites are released in the environment, and can be frequently detected in wastewater, surface water, and importantly in drinking water.

View Article and Find Full Text PDF

Background: Congenital nail matrix nevi (NMN) are difficult to diagnose because they feature clinical characteristics suggestive of adult subungual melanoma. Nail matrix biopsy is difficult to perform, especially in children.

Objective: To describe the initial clinical and dermatoscopic features of NMN appearing at birth (congenital) or after birth but before the age of 5 years (congenital-type).

View Article and Find Full Text PDF

Background: PSAP encodes saposin C, the co-activator of glucocerebrosidase, encoded by GBA. GBA mutations are associated with idiopathic/isolated REM sleep behavior disorder (iRBD), a prodromal stage of synucleinopathy.

Objective: To examine the role of PSAP mutations in iRBD.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the effectiveness of counting circulating tumor cells (CTCs) using the EPISPOT assay and the CellSearch system in predicting treatment outcomes in patients with metastatic colorectal cancer (mCRC).
  • Results show that the presence of viable CTCs detected by EPISPOT is linked to shorter progression-free survival (PFS) and overall survival (OS) in patients, indicating its predictive value.
  • Overall, the findings suggest that monitoring CTC dynamics, particularly with the EPISPOT assay, may help anticipate how well patients respond to treatment.
View Article and Find Full Text PDF

Novel Associations of and With REM Sleep Behavior Disorder.

Neurology

March 2021

From the Department of Human Genetics (K.M., E.Y., U.R., L.K., G.A.R., Z.G.-O.), Montreal Neurological Institute (K.M., E.Y., U.R., L.K., J.A.R., F.A., S.B.L., D.S., G.A.R., R.B.P., Z.G.-O.), Department of Neurology and Neurosurgery (J.A.R., F.A., S.B.L., D.S., G.A.R., R.B.P., Z.G.-O.), Centre de Recherche en Biologie Structurale (J.-F.T.), and Department of Pharmacology and Therapeutics (J.-F.T.), McGill University, Montréal, Quebec, Canada; Sleep Disorders Unit (I.A.), Pitié Salpêtrière Hospital, Paris Brain Institute and Sorbonne University, France; Oxford Parkinson's Disease Centre (OPDC) (M.T.M.H.) and Nuffield Department of Clinical Neurosciences (M.T.M.H.), University of Oxford, UK; Center for Advanced Research in Sleep Medicine (J.Y.M., J.-F.G., A.D., R.B.P.), Centre Intégré Universitaire de Santé et de Services Sociaux du Nord-de-l'Île-de-Montréal-Hôpital du Sacré-Coeur de Montréal; Departments of Psychiatry (J.Y.M.) and Neurosciences (A.D.), Université de Montréal; Department of Psychology (J.-F.G.), Université du Québec à Montréal, Canada; National Reference Center for Narcolepsy (Y.D.), Sleep Unit, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, University of Montpellier, Inserm U1061, France; Clinical Neurology Unit (G.L.G., M.V., F.J., A.B.), Department of Neurosciences, University Hospital of Udine; DMIF (G.L.G.) and Department of Medicine (DAME) (M.V.), University of Udine, Italy; Sleep Disorders Clinic (B.H., A.S., E.H.), Department of Neurology, Medical University of Innsbruck, Austria; Department of Neurology (K.S., D.K.) and Centre of Clinical Neuroscience (K.S., D.K.), Charles University, First Faculty of Medicine and General University Hospital, Prague, Czech Republic; Department of Neurology (W.O., A.J., F.S.-D.), Philipps University, Marburg, Germany; Department of Biomedical, Metabolic and Neural Sciences (G.P.), University of Modena and Reggio-Emilia; IRCCS (G.P.), Institute of Neurological Sciences of Bologna; Neurology Unit (E.A.), Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona; Department of Medical Sciences and Public Health (M.F., M.P.), Sleep Disorder Research Center, University of Cagliari, Italy; Paracelsus-Elena-Klinik (B.M., C.T., F.S.-D.), Kassel; Department of Neurosurgery (B.M., C.T.), University Medical Centre Göttingen, Germany; Sleep and Neurology Unit (V.C.D.C.), Beau Soleil Clinic; EuroMov Digital Health in Motion (V.C.D.C.), University of Montpellier IMT Mines Ales; University Lille North of France (C.C.M.), Department of Clinical Neurophysiology and Sleep Center, CHU Lille; Department of Sleep Medicine and Neuromuscular Disorders (A.H.), University of Müenster, Germany; Department of Neurological Sciences (L.F.-S.), Università Vita-Salute San Raffaele, Milan, Italy; Laboratory for Sleep Disorders (F.D., M.V.) and Department of Neurology (F.D., M.V.), St. Dimpna Regional Hospital, Geel; Department of Neurology (F.D.), University Hospital Antwerp, Edegem, Belgium; Sleep Disorder Unit (B.A.), Carémeau Hospital, University Hospital of Nîmes, France; and Department of Neurology (B.F.B.), Mayo Clinic, Rochester, MN.

Objective: To examine the role of genes identified through genome-wide association studies (GWASs) of Parkinson disease (PD) in the risk of isolated REM sleep behavior disorder (iRBD).

Methods: We fully sequenced 25 genes previously identified in GWASs of PD in a total of 1,039 patients with iRBD and 1,852 controls. The role of rare heterozygous variants in these genes was examined with burden tests.

View Article and Find Full Text PDF